《公司业绩》利兴发展(00068.HK)全年亏损收窄至4.46亿元
利兴发展(00068.HK)公布截至去年12月底止全年业绩,营业额1,702.4万元,按年跌15.6%。亏损收窄至4.46亿元,上年同期蚀4.82亿元;每股亏损304.19仙。不派息。
核数师就报告发表保留意见,指无法为有关该两项投资确认於综合损益表中的公平值转变,包括分别在综合损益表中「按公平值计入损益之财务资产–上市投资之净亏损」的出售PureCircle Limited股本权益之亏损3.03亿元,及「收入及收益」的出售Ingredion SRSS Holdings Limited之B普通股之溢利911.8万元的准确性取得适当的凭证。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.